Literature DB >> 22521583

Chronic nicotine exposure inhibits estrogen-mediated synaptic functions in hippocampus of female rats.

Ami P Raval1, Justin T Sick, Gabriel J Gonzalez, R Anthony Defazio, Chuanhui Dong, Thomas J Sick.   

Abstract

Nicotine, the addictive agent in cigarettes, reduces circulating estradiol-17β (E₂) and inhibits E₂-mediated intracellular signaling in hippocampus of female rats. In hippocampus, E₂-signaling regulates synaptic plasticity by phosphorylation of the N-methyl-D-aspartic acid receptor subunit NR2B and cyclic-AMP response element binding protein (pCREB). Therefore, we hypothesized that chronic nicotine exposure induces synaptic dysfunction in hippocampus of female rats. Female rats were exposed to nicotine or saline for 16 days followed by electrophysiological analysis of hippocampus. Briefly, population measurements of excitatory post-synaptic field potentials (fEPSPs) were recorded from stratum radiatum of the CA1 hippocampal slice subfield. A strict software-controlled protocol was used which recorded 30 min of baseline data (stimulation rate of 1/min), a paired-pulse stimulation sequence followed by tetanic stimulation, and 1h of post-tetanus recording. EPSP amplitude and the initial EPSP slope were measured off-line. We then investigated by Western blot analysis the effects of nicotine on hippocampal estrogen receptor-beta (ER-β), NR2B and pCREB. The results demonstrated significantly decreased post-tetanic potentiation and paired-pulse facilitation at the 40, and 80 ms interval in nicotine-exposed rats compared to the saline group. Western blot analysis revealed that nicotine decreased protein levels of ER-β, NR2B, and pCREB. We also confirmed the role of E₂ in regulating NR2B and pCREB phosphorylation by performing Western blots in hippocapmal tissue obtained from E₂-treated ovariectomized rats. In conclusion, chronic nicotine exposure attenuates short-term synaptic plasticity, and the observed synaptic defects might be a consequence of loss of estradiol-17β-signaling. However, determining the exact molecular mechanisms of chronic nicotine exposure on synaptic plasticity specific to the female brain require further investigation.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521583     DOI: 10.1016/j.neulet.2012.04.015

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.

Authors:  Meghan O Blaya; Joseph M Wasserman; Andrew A Pieper; Thomas J Sick; Helen M Bramlett; W Dalton Dietrich
Journal:  Neuropharmacology       Date:  2018-09-17       Impact factor: 5.250

2.  Oral contraceptives and nicotine synergistically exacerbate cerebral ischemic injury in the female brain.

Authors:  Ami P Raval; Raquel Borges-Garcia; Francisca Diaz; Thomas J Sick; Helen Bramlett
Journal:  Transl Stroke Res       Date:  2013-02-13       Impact factor: 6.829

3.  Re-Opening the Critical Window for Estrogen Therapy.

Authors:  Linda A Bean; Ashok Kumar; Asha Rani; Mike Guidi; Awilda M Rosario; Pedro E Cruz; Todd E Golde; Thomas C Foster
Journal:  J Neurosci       Date:  2015-12-09       Impact factor: 6.167

Review 4.  Sex Differences in the Nicotinic Acetylcholine Receptor System of Rodents: Impacts on Nicotine and Alcohol Reward Behaviors.

Authors:  Janna K Moen; Anna M Lee
Journal:  Front Neurosci       Date:  2021-09-21       Impact factor: 4.677

5.  Analysis of kalirin-7 knockout mice reveals different effects in female mice.

Authors:  Christopher M Mazzone; Taylor P Larese; Drew D Kiraly; Betty A Eipper; Richard E Mains
Journal:  Mol Pharmacol       Date:  2012-09-18       Impact factor: 4.436

6.  Nicotine Alters Estrogen Receptor-Beta-Regulated Inflammasome Activity and Exacerbates Ischemic Brain Damage in Female Rats.

Authors:  Nathan D d'Adesky; Juan Pablo de Rivero Vaccari; Pallab Bhattacharya; Marc Schatz; Miguel A Perez-Pinzon; Helen M Bramlett; Ami P Raval
Journal:  Int J Mol Sci       Date:  2018-04-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.